Clinton Health Access Initiative is hiring a Director, GMT

The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems. CHAI was founded in 2002 in response to the HIV/AIDS epidemic, with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally. At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication, and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries. Learn more about our exciting work: http://www.clintonhealthaccess.org CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture. Team Overview The CHAI Global Markets Team (GMT) supports CHAI’s diverse programs in achieving sustainable access to best-in-class drugs and diagnostic tests. GMT is responsible for leading, designing, negotiating, and supporting the effective implementation of market shaping interventions and access programs that increase the uptake of critical health commodities in LMICs. Market-shaping interventions range from traditional policy-led and grant-financed initiatives such as pooled procurement, coordinated ordering, and strategic demand forecasting to more innovative mechanisms such as volume guarantees (VGs), product development incentives, advance market commitments (AMCs), and working capital facilities. Examples of programs developed and led by GMT include the following: CHAI in partnership with DRL announced HIV prevention drug Lenacapavir to be launched at $40. This is pathbreaking, and President Clinton announced this himself at UNGA 2026. A generic version of the drug will be made available in record time. CHAI and The Hepatitis Fund announce pricing breakthrough to reduce cost of viral hepatitis treatment by over 90 percent New agreement secures historic US$1 price for HIV self-test Global partnership to make available 120M affordable, quality COVID-19 rapid tests for low- and middle-income countries Price reduction agreement for contraceptive implants increased distribution by >50% and will save more than US$300M The GMT collaborates with internal and external stakeholders on both the supply- and demand-sides of the market to assess the potential public-health impact of proposed market-shaping interventions. The GMT also takes the lead within CHAI in developing access programs and managing relationships with global and regional life science companies. Position Overview CHAI pioneered and developed the practice of market shaping interventions for public health in LMICs. The Director GMT builds relationships with CHAI’s country and program leadership teams, working in partnerships to develop, provide and lead and /or support the execution of the strategies and programs to sustain CHAI’s leadership role in market shaping globally and in country, across a broad portfolio of health products and services. The Director GMT demonstrates an unwavering commitment to advancing CHAI’s mission and consistently embodies CHAI’s Values in their interactions with staff and partners. She/he is a highly respected individual who provides inspiration and thought leadership to peers and team members. The Director GMT is a member of CHAI GMT’s Senior Leadership Team and reports to the VP and head of GMT and the Market Shaping Cluster. The Director is responsible for leading and managing a high-performing, talented and diverse group of staff based in the US, India, Africa, and Europe, and effectively working cross-functionally, to deliver on both GMT goals and relevant market-shaping program goals. She/he will have a proven track record of actively enlisting and developing and mentoring high potential talent on their teams. The Director has budgetary responsibility for his/her team within GMT and may also take the lead in managing GMT grants and/or co-managing some large program grants. The Director will be responsible for working alongside the VP GMT to define, build and maintain a “fit for purpose” structure for GMT, including mobilizing resources to support GMT’s “fit for purpose” model, including strengthening GMT’s integrated One Team approach with program and country teams. The Director will be a senior negotiator within GMT and will be responsible for leading negotiations on key market-shaping interventions and mentoring staff as it relates to supplier negotiations. He/she will be responsible for engaging actively in defining program strategies and leading the execution of the market-shaping aspects of those strategies. He/she will also be responsible for creating and managing opportunities for CHAI’s sector influence, e.g. at strategic global level, to enhance CHAI's leading position as a global market shaper. They will also support CHAI’s market-shaping goals and catalyse broader transformational change. The Director must demonstrate domain experience and expertise in the following areas: negotiating product deals/access agreements with biopharmaceutical and diagnostic companies biopharmaceutical and diagnostic industry operations, as well as the development, manufacturing, and commercialization of drugs and diagnostics establishing sector influence by aligning various global health partners, from governments to donors, procurers, and guarantors, supporting deals market analysis and market research country and global regulatory systems for the approval of new drugs and diagnostics global public health funding and policy setting proven ability to manage the global health political ecosystem multilateral funded health care programs in areas such as Malaria, TB, HIV, and Nutrition working effectively across a complex organizational matrix, including varying countries support CHAI Country teams to improve access to health commodities. As a senior leader within the organization, the Director will be actively engaged in business development, managing donor relationships, supporting major grant submissions made by GMT and/or program teams, building long term collaborative relationships with peers in funding organizations. He will also develop innovative programs that attract new donors to CHAI.